360 related articles for article (PubMed ID: 21357831)
21. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
[TBL] [Abstract][Full Text] [Related]
22. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
23. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Höftberger R; Boronat A; Saiz A; Dalmau J; Graus F
PLoS One; 2013; 8(3):e60438. PubMed ID: 23536908
[TBL] [Abstract][Full Text] [Related]
24. Immunology of stiff person syndrome and other GAD-associated neurological disorders.
Alexopoulos H; Dalakas MC
Expert Rev Clin Immunol; 2013 Nov; 9(11):1043-53. PubMed ID: 24168411
[TBL] [Abstract][Full Text] [Related]
25. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?
Blanc F; Ruppert E; Kleitz C; Valenti MP; Cretin B; Humbel RL; Honnorat J; Namer IJ; Hirsch E; Manning L; de Seze J
J Neurol Sci; 2009 Dec; 287(1-2):69-71. PubMed ID: 19786284
[TBL] [Abstract][Full Text] [Related]
26. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.
Graus F; Saiz A; Lai M; Bruna J; López F; Sabater L; Blanco Y; Rey MJ; Ribalta T; Dalmau J
Neurology; 2008 Sep; 71(12):930-6. PubMed ID: 18794496
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
[TBL] [Abstract][Full Text] [Related]
28. Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis.
Mazzi G; Roia DD; Cruciatti B; Matà S; Catapano R
Transfus Apher Sci; 2008 Dec; 39(3):229-33. PubMed ID: 18955013
[TBL] [Abstract][Full Text] [Related]
29. Early and chronic gray matter volume changes in limbic encephalitis revealed by voxel-based morphometry.
Wagner J; Weber B; Elger CE
Epilepsia; 2015 May; 56(5):754-61. PubMed ID: 25809952
[TBL] [Abstract][Full Text] [Related]
30. Clinical spectrum of glutamic acid decarboxylase antibodies in a Taiwanese population.
Kuo YC; Lin CH
Eur J Neurol; 2019 Nov; 26(11):1384-1390. PubMed ID: 31132202
[TBL] [Abstract][Full Text] [Related]
31. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
[TBL] [Abstract][Full Text] [Related]
32. GAD antibodies in neurological disorders - insights and challenges.
Graus F; Saiz A; Dalmau J
Nat Rev Neurol; 2020 Jul; 16(7):353-365. PubMed ID: 32457440
[TBL] [Abstract][Full Text] [Related]
33. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
Manto MU; Laute MA; Aguera M; Rogemond V; Pandolfo M; Honnorat J
Ann Neurol; 2007 Jun; 61(6):544-51. PubMed ID: 17600364
[TBL] [Abstract][Full Text] [Related]
34. Voltage-gated potassium channel antibodies in limbic encephalitis.
Pozo-Rosich P; Clover L; Saiz A; Vincent A; Graus F
Ann Neurol; 2003 Oct; 54(4):530-3. PubMed ID: 14520669
[TBL] [Abstract][Full Text] [Related]
35. Long latency between GAD-antibody detection and development of limbic encephalitis--a case report.
Fauser S; Uttner I; Ariño H; Scherbaum WA; Saiz A; Lewerenz J
BMC Neurol; 2015 Sep; 15():177. PubMed ID: 26420440
[TBL] [Abstract][Full Text] [Related]
36. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neural Transm (Vienna); 2017 Oct; 124(10):1171-1182. PubMed ID: 28689294
[TBL] [Abstract][Full Text] [Related]
37. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies.
Matà S; Muscas GC; Naldi I; Rosati E; Paladini S; Cruciatti B; Bisulli F; Paganini M; Mazzi G; Sorbi S; Tinuper P
J Neuroimmunol; 2008 Aug; 199(1-2):155-9. PubMed ID: 18586329
[TBL] [Abstract][Full Text] [Related]
38. Stiff Person syndrome and other anti-GAD-associated neurologic disorders.
Dayalu P; Teener JW
Semin Neurol; 2012 Nov; 32(5):544-9. PubMed ID: 23677666
[TBL] [Abstract][Full Text] [Related]
39. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
[TBL] [Abstract][Full Text] [Related]
40. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders.
Fouka P; Alexopoulos H; Akrivou S; Trohatou O; Politis PK; Dalakas MC
J Neuroimmunol; 2015 Apr; 281():73-7. PubMed ID: 25867471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
